Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis.

Cerebrovascular diseases (Basel, Switzerland) - 1 Jan 2005

Gadelha Telma, André Charles, Jucá Andreza A V, Nucci Márcio

Abstract excerpt

BACKGROUND: This study investigates the association between cerebral vein thrombosis (CVT) and the mutations FV 1691A (factor V Leiden), PT 20210A and MTHFR 677TT and acquired factors including oral contraceptive (OC) use. METHODS: 26 patients (21 females) and 217 healthy controls (134 females) were studied. Multiple regression analysis was performed. RESULTS: The frequency of the three mutations in cases and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Child, Preschool
Share to Contraceptives, Oral, Hormonal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Intracranial Thrombosis

Share to Prevalence

Share to Prothrombin

Share to Risk Factors

Share to Venous Thrombosis

Source

Identifiers

PMID: 15528884
DOI: 10.1159/000081911

Genes

MTHFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis.PMID 15528884Read ↗

High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.Semantic proximity Read ↗

An unusual cause of cerebral venous sinus thrombosis: prothrombin G20210A gene mutation.Semantic proximity Read ↗

Prothrombin gene variant (G20210A) in a patient with cerebral venous sinus thrombosis.Semantic proximity Read ↗

Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis.Semantic proximity Read ↗

Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis.Semantic proximity Read ↗

Clinical significance of factor V Leiden and prothrombin G20210A-mutations in cerebral venous thrombosis - comparison with arterial ischemic stroke.Semantic proximity Read ↗

The role of genetics in the risk of thromboembolism: prothrombin 20210A and oral contraceptive therapy.Semantic proximity Read ↗

Non-genetic and genetic risk factors for adult cerebral venous thrombosis.Semantic proximity Read ↗

Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.Semantic proximity Read ↗

MTHFR Gene Polymorphisms and Cardiovascular Risk Factors, Clinical-Imagistic Features and Outcome in Cerebral Venous Sinus ThrombosisSemantic proximity Read ↗

Inherited prothrombotic risk factors and cerebral venous thrombosis.Semantic proximity Read ↗

Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.